FDA authorized InBios COVID-19 over-the-counter antigen test
On Nov. 22, 2021, the U.S. Food and Drug Administration authorized another over-the-counter (OTC) COVID-19 antigen test.
The FDA issued an emergency use authorization (EUA) for the InBios SCoV-2 Ag Detect Rapid Self-Test, an OTC COVID-19 antigen diagnostic test that delivers results in about 20 minutes.
Tags:
Source: U.S. Food and Drug Administration
Credit: